FDA Approves Oral Antiviral Pill for High-Risk COVID-19 Patients
Pfizer's Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA to treat COVID-19 in adults.
Pfizer's Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA to treat COVID-19 in adults.